Asim Kichloo

Asim Kichloo is a Senior Professor and Chair of Internal Medicine and Geriatrics at the University of North Texas Health Science Center. His research focuses on critical care outcomes, cardiovascular disease, and epidemiology, with particular emphasis on atrial fibrillation management in obese patients, acute kidney injury in the intensive care unit, and acute respiratory distress syndrome. His recent publications include studies on the impact of chronic kidney disease on ARDS outcomes (Canadian Respiratory Journal, 2026) and comparative efficacy of novel therapies for chronic lymphocytic leukemia, including venetoclax and zanubrutinib meta-analyses (Annals of Hematology, 2025). He has also contributed to hematology-oncology research on blinatumomab-treated acute lymphoblastic leukemia (American Journal of Clinical Oncology, 2025). His work integrates public health perspectives with clinical outcomes research to optimize management strategies for complex, multi-morbid patient populations.